NCT05059548

Brief Summary

Video-Assisted Thoracoscopic Surgery(VATS) is among the most common and disabling persistent pain and inflammation conditions, with increasing prevalence in the developed world, and affects women to a greater degree than men. And sleep disruption also remains a challenging problem in surgical settings. Postoperative sleep disturbances (POSD) are defined as changes in the sleep structure and quality of patients during the early stages after surgery, which are manifested as significantly shortened rapid eye movement (REM) sleep, prolonged awake time, and sleep fragmentation. Long-term POSD may increase the risk of postoperative delirium or cognitive dysfunction and delay recovery, thereby worsening the patient's physical condition. The aim of the study was to investigate the effect of sex differences on postoperative pain, inflammation, sleep quality and cognitive function among patients who have undergone video-assisted thoracoscopic surgery under general anesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

September 20, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 28, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

3 months

First QC Date

September 12, 2021

Last Update Submit

September 20, 2021

Conditions

Outcome Measures

Primary Outcomes (12)

  • sleep quality of one night before surgery

    use the athens insomnia scale to evaluate subjective sleep quality (0 to 24 points, with ≥ 6 points indicating a diagnosis of insomnia)

    one night before surgery

  • sleep quality of first night after surgery

    use the athens insomnia scale to evaluate subjective sleep quality (0 to 24 points, with ≥ 6 points indicating a diagnosis of insomnia)

    first night after surgery

  • sleep quality of third night after surgery

    use the athens insomnia scale to evaluate subjective sleep quality (0 to 24 points, with ≥ 6 points indicating a diagnosis of insomnia)

    third night after surgery

  • preoperative inflammation function

    evaluate systemic immune inflammation index (SII) before operation

    three days before surgery

  • preoperative inflammation function

    evaluate neutrophil / lymphocyte ratio (NLR)before operation

    three days before surgery

  • preoperative inflammation function

    evaluate platelet / lymphocyte ratio (PLR) before operation

    three days before surgery

  • preoperative inflammation function

    evaluate monocyte / lymphocyte ratio (MLR) before operation

    three days before surgery

  • postoperative inflammation function

    evaluate systemic immune inflammation index (SII) after operation

    three days after surgery

  • postoperative inflammation function

    evaluate neutrophil / lymphocyte ratio (NLR) after operation

    three days after surgery

  • postoperative inflammation function

    evaluate platelet / lymphocyte ratio (PLR) after operation

    three days after surgery

  • postoperative inflammation function

    evaluate monocyte / lymphocyte ratio (MLR) after operation

    three days after surgery

  • neuropsychological test

    The neuropsychological test battery included the tests used to evaluate patients for delayed neurocognitive recovery in the International Study of Post-Operative Cognitive Dysfunction: (1) word learning: visual verbal learning test based on the Rey's auditory recall of words; (2) word recall: the number or words recalled from visual verbal learning trials after a 20-min delay; (3) cognitive flexibility: including trail making test A and B; (4) distractibility: Stroop color word interference test; and (5) working memory: letter-digit coding. If a patient exhibited delirium at a testing time, neuropsychological evaluation was postponed 3 days.

    Neuropsychological tests were carried out the day before and 5 to 7 days after surgery. The second neuropsychological test time for control subjects was 6 to 9 d

Secondary Outcomes (2)

  • visual analog scale(VAS) score after surgery

    24 hours after surgery

  • postoperative adverse effects

    24 hours after surgery

Study Arms (2)

Male Group

Video-Assisted Thoracoscopic Surgery patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia

Other: Video-Assisted Thoracoscopic Surgery

Female Group

Video-Assisted Thoracoscopic Surgery patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia

Other: Video-Assisted Thoracoscopic Surgery

Interventions

patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia

Female GroupMale Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients undergoing video-assisted thoracoscopic surgery under general anesthesia

You may qualify if:

  • years old
  • ASA I-III
  • under general anesthesia

You may not qualify if:

  • patients with central nervous system and mental diseases;
  • patients with preoperative sleep disturbances;
  • patients with a history of sedative, analgesic, or antidepression drug use;
  • patients with sleep apnea or moderate and severe obstructive sleep apneahypopnea syndrome;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shengjing Hospital

Shenyang, Liaoning, 110004, China

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Thoracic Surgery, Video-Assisted

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

ThoracoscopyEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisVideo-Assisted SurgeryMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Officials

  • junchao zhu

    Shengjing Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

September 12, 2021

First Posted

September 28, 2021

Study Start

September 20, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

September 28, 2021

Record last verified: 2021-09

Locations